Page last updated: 2024-12-06

geranylacetone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

geranyl acetone : A monoterpene ketone in which an (E)-geranyl group is bonded to one of the alpha-methyls of acetone. It is a component of essential oils from various plants including Nelumbo nucifera. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

FloraRankFlora DefinitionFamilyFamily Definition
NelumbogenusA plant genus of the family NELUMBONACEAE. The common name lotus is also used for other plants such as the WATER-LILY, which they resemble, and the unrelated genus Lotus (LOTUS). Nelumbo produce the edible lotus nuts.[MeSH]NelumbonaceaeA plant family of the order Nymphaeales, subclass Magnoliidae, class Magnoliopsida. They are aquatic plants.[MeSH]

Cross-References

ID SourceID
PubMed CID1549778
CHEBI ID67206
SCHEMBL ID112855
SCHEMBL ID112856
MeSH IDM0054953

Synonyms (69)

Synonym
STK709221
trans-geranylacetone
5,9-undecadien-2-one, 6,10-dimethyl-, (e)-
5,9-undecadien-2-one, 6,10-dimethyl-
3796-70-1
(5e)-6,10-dimethylundeca-5,9-dien-2-one
nsc406679
nsc-406679
dihydropseudoionone
5, 6,10-dimethyl-
689-67-8
6,10-dimethyl-5,9-undecadien-2-one, >=97%, stabilized, fg
geranylacetone ,
(e)-6,10-dimethyl-5,9-undecadien-2-one
5,9-undecadien-2-one, 6,10-dimethyl-, (5e)-
(e)-6,10-dimethylundeca-5,9-dien-2-one
6,10-dimethyl-5,9-undecadien-2-one, trans-
geranylacetone, trans-
6,10-dimethyl-5,9-undecadien-2-one, (e)-
geranyl acetone
fema no. 3542
einecs 223-269-8
2,6-dimethyl-2,6-undecadien-2-one, trans-
6,10-dimethyl-5,9-undecadien-2-one
geranyl-2-propanone
G0236
A836300
NCGC00249179-01
(5e)-6,10-dimethyl-5,9-undecen-2-one
6,10-dimethyl-(e)-5,9-undecadien-2-one
trans-6,10-dimethyl-5,9-undecadien-2-one
(e)-geranylacetone
6,10-dimethyl-5(e),9-undecadien-2-one
LMFA11000696
dtxcid901586
NCGC00256556-01
tox21_302933
cas-689-67-8
tox21_202156
NCGC00259705-01
AKOS005522601
unii-9b7ry79u9z
9b7ry79u9z ,
einecs 269-400-2
CHEBI:67206
6,10-dimethyl-5,9-undecadien-2-one [fhfi]
e-geranyl acetone
e-geranylacetone
SCHEMBL112855
SCHEMBL112856
BBL027735
DTXSID4052053
W-104645
.alpha.,.beta.-dihydropseudoionone
2,6-dimethylundeca-2,6-dien-10-one
sr-01000526349
SR-01000526349-1
geranylacetone, (e)+(z), 97%, (z)-isomer (nerylacetone) ca 45%
Q27135687
cis,trans-geranylacetone
(4-trifluoromethyl-phenyl)-phosphonicacid
geranylacetone (mixture of isomers)
AC1127
AMY806
CS-0144246
EN300-125485
6,10-dimethyl-5,9-undecadien-2-on
HY-N8446
(5e)-6,10-dimethyl-2-undeca-5,9-dienone
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (4)

RoleDescription
flavouring agentA food additive that is used to added improve the taste or odour of a food.
fragranceA substance, extract, or preparation for diffusing or imparting an agreeable or attractive smell.
volatile oil componentAny plant metabolite that is found naturally as a component of a volatile oil.
plant metaboliteAny eukaryotic metabolite produced during a metabolic reaction in plants, the kingdom that include flowering plants, conifers and other gymnosperms.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
monoterpene ketoneA terpene ketone derived from a monoterpene.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (9)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
GLI family zinc finger 3Homo sapiens (human)Potency36.47350.000714.592883.7951AID1259369; AID1259392
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency50.90480.003041.611522,387.1992AID1159552; AID1159553; AID1159555
farnesoid X nuclear receptorHomo sapiens (human)Potency13.86810.375827.485161.6524AID743220
pregnane X nuclear receptorHomo sapiens (human)Potency54.48270.005428.02631,258.9301AID1346982
estrogen nuclear receptor alphaHomo sapiens (human)Potency4.36470.000229.305416,493.5996AID743069
activating transcription factor 6Homo sapiens (human)Potency2.19790.143427.612159.8106AID1159516
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_aHomo sapiens (human)Potency0.007819.739145.978464.9432AID1159509
heat shock protein beta-1Homo sapiens (human)Potency61.65240.042027.378961.6448AID743210
nuclear factor erythroid 2-related factor 2 isoform 1Homo sapiens (human)Potency48.55770.000627.21521,122.0200AID743219
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (27)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (7.41)18.7374
1990's0 (0.00)18.2507
2000's7 (25.93)29.6817
2010's13 (48.15)24.3611
2020's5 (18.52)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (3.70%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other26 (96.30%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]